Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
about
HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor bindingCrystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteinsHeptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediateFunctional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entryStructural and functional anatomy of the globular domain of complement protein C1q.Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathwayMolecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101.71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry.Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide.Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.
P2860
Q24791507-190721C2-5B87-4168-B92C-0AE3D8B2C3BAQ27617901-DC380430-499B-4106-96AB-271B9E4639BAQ30448708-317E6CDE-D6D3-4A92-92EA-5D3A03778A95Q33843696-9FB50DE6-9346-4801-9397-5E04946A59FEQ33853769-9820627A-0381-494C-BCAC-BA1F0524BD8EQ34756124-9152559B-BD1D-455A-AF4E-523FF5ECA026Q35857748-C9BED665-0468-48DE-A81D-6D91C6C10A53Q35896873-BDBCB577-E81A-47F6-9F27-9809445FEA30Q36424025-75FDBE3C-474E-418B-9EE7-2A771A23B093Q36690145-7AE5293E-432D-4EB7-A72F-7FC8F48A2E77Q39139856-370AA356-B348-46AF-A4BC-7BF0F4395C58Q39577314-9C09A599-8376-488A-9B4B-E4FAED0D0C78Q39580518-C9489157-F030-4916-9121-7F44E5557193Q39596759-F95D542C-F110-4C12-807D-D4CB3A388685Q39604783-07F397B9-E3DE-440B-ABC0-6B5E72C09BF6Q39877808-BF64BD41-F04B-48BB-BC9B-A4E6B10EE3F3Q40008331-26C49282-DEC9-4502-BFDE-1E494FBA4DA1Q40340446-9FFFD992-4031-4C1C-98E3-A800A9DC67BCQ41834173-E67C47A5-8AF5-4E2A-BF4D-477591D9C56C
P2860
Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Identification and mapping of ...... s by using synthetic peptides.
@ast
Identification and mapping of ...... s by using synthetic peptides.
@en
type
label
Identification and mapping of ...... s by using synthetic peptides.
@ast
Identification and mapping of ...... s by using synthetic peptides.
@en
prefLabel
Identification and mapping of ...... s by using synthetic peptides.
@ast
Identification and mapping of ...... s by using synthetic peptides.
@en
P2093
P2860
P1433
P1476
Identification and mapping of ...... ns by using synthetic peptides
@en
P2093
P2860
P304
P407
P577
1996-03-01T00:00:00Z